De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system

Pediatric Blood and Cancer

Volumn 53, Issue 7, 2009, Pages 1352-1354

  Schniederjan, Matthew J ^a   Shehata, Bahig ^a   Brat, Daniel J ^a   Esiashvili, Natia ^a   Janss, Anna J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Li Fraumeni; p53; Synchronous tumors

Indexed keywords

PROTEIN P53; ANTINEOPLASTIC AGENT; CISPLATIN; LOMUSTINE; VINCRISTINE;

ADOLESCENT; ALLELE; ARTICLE; CANCER SURGERY; CASE REPORT; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS CARCINOMA; CHOROID PLEXUS TUMOR; CODON; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; GENE MUTATION; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; MALE; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYLOGENY; PRIORITY JOURNAL; ADJUVANT THERAPY; BRAIN TUMOR; CANCER OF UNKNOWN PRIMARY SITE; CARCINOMA; FATALITY; FRONTAL LOBE; GENETICS; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CANCER; MUTATION; PATHOLOGY; RHABDOMYOSARCOMA; SKULL IRRADIATION; SPINAL CORD TUMOR; STOP CODON; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA; CHOROID PLEXUS NEOPLASMS; CISPLATIN; CODON, NONSENSE; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FATAL OUTCOME; FRONTAL LOBE; GENES, P53; GERM-LINE MUTATION; HUMANS; LOMUSTINE; MALE; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, UNKNOWN PRIMARY; NEUROECTODERMAL TUMORS, PRIMITIVE; RADIOTHERAPY, ADJUVANT; RHABDOMYOSARCOMA, ALVEOLAR; SPINAL NEOPLASMS; VINCRISTINE;

EID: 70449732665     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22214     Document Type: Article

References (20)

1. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
2. Varley JM, McGown G, Thorncroft M, et al. Germ-line mutations of TP53 in Li-Fraumeni families: An extended study of 39 families. Cancer Res 1997;57:3245-3252.
3. Li FP, Fraumeni JF, Jr. Soft-tissue sarcomas, breast cancer and other neoplasms: A familial syndrome? Ann Intern Med 1969;71:747-752.
4. Li FP, Fraumeni JF, Jr., Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988;48:5358-5362.
5. Nichols KE, Malkin D, Garber JE, et al. Li FP Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001;10:83-87.
6. Patrikidou A, Bennett J, Abou-Sleiman P, et al. A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla. Oral Oncol 2002;38:383-390.
7. Nogales FF, Musto ML, Sáez AI, et al. Multifocal intrafollicular granulosa cell tumor of the ovary associated with an unusual germline p53 mutation. Mod Pathol 2004;17:868-873.
8. Cavalier ME, Davis MM, Croop JM. Germline p53 mutation presenting as synchronous tumors. J Pediatr Hematol Oncol 2005;27:441-443.
9. Petitjean A, Mathe E, Kato S, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum Mutat 2007;28:622-629.
10. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors. 5th edition. Philadelphia, PA: Mosby; 2007.
11. Nichols KE, Malkin D, Garber JE, et al. Li FP Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001;10:83-87.
12. Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: Correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003;63:6643-6650.
13. Krutilkova V, Trkova M, Fleitz J, et al. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations. Eur J Cancer 2005;41:1597-1603.
14. Pellegata NS, Cajot JF, Stanbridge EJ. The basic carboxy-terminal domain of human p53 is dispensable for both transcriptional regulation and inhibition of tumor cell growth. Oncogene 1995;11:337-349.
15. Plon SE, Pirics ML, Nuchtern J, et al. Multiple tumors in a child with germ-line mutations of p53 and PTEN. N Engl J Med 2008;359:537-539.
16. Pivnick EK, Furman WL, Velagaleti GV, et al. Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation. J Med Genet 1998;35:328-332.
17. Roque L, Lacerda A, Rodrigues R, et al. CGH evaluation of two de novo synchronous tumors in a child with a germline p53 mutation. Pediatr Blood Cancer 2006;47:949-954.
18. Cavalier ME, Davis MM, Croop JM. Germline p53 mutation presenting as synchronous tumors. J Pediatr Hematol Oncol 2005;27:441-443.
19. Gutiérrez MI, Bhatia KG, Barreiro C, et al.Ade novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors. Hum Mol Genet 1994;3:2247-2248.
20. Monti P, Ciribilli Y, Jordan J, et al. Transcriptional functionality of germ line p53 mutants influences cancer phenotype. Clin Cancer Res 2007;13:3789-3795.